Cardinal Healthcare recalls Inhub Wixela (fluticasone propionate and salmeterol inhalation powder
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
- Products
-
- Inhub Wixela (fluticasone propionate and salmeterol inhalation powder
- Company
- Cardinal Healthcare
- Where it was sold
-
Nationwide USA
Nationwide
- Units affected
- 1 unit
- About this recall
- Inhub Wixela (fluticasone propionate and salmeterol inhalation powder, USP) 500/50MCG, 60 Doses of Inhalation Powder, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505. NDC: 0378-9320-32